84 related articles for article (PubMed ID: 21413852)
41. Stage 1 testicular seminoma: radiotherapy.
Beck SD
J Urol; 2015 Jun; 193(6):1887-8. PubMed ID: 25791403
[No Abstract] [Full Text] [Related]
42. Low-dose radiotherapy for stage I seminoma: early results.
Kiricuta IC; Bohndorf W
Radiother Oncol; 1996 Oct; 41(1):96-7. PubMed ID: 8961375
[No Abstract] [Full Text] [Related]
43. Testicular cancer: Underestimating radiotherapy toxicity for stage I seminoma.
Pfanzelter N; Bekelman JE
Nat Rev Urol; 2012 Apr; 9(5):241-2. PubMed ID: 22508457
[No Abstract] [Full Text] [Related]
44. Alternative management options to radiation therapy for stage I and IIA testicular seminoma.
Thomas GM
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):547-8. PubMed ID: 8276674
[No Abstract] [Full Text] [Related]
45. Role of radiotherapy in organ-sparing treatment of seminoma.
Flaquer A; Alvarez A; Sánchez SM
Clin Transl Oncol; 2008 Oct; 10(10):679-81. PubMed ID: 18940752
[TBL] [Abstract][Full Text] [Related]
46. Renal artery stenosis after radiotherapy for stage I seminoma, a case report.
Mulla MG; Ananthkrishnan G; Mirza MS; Bungay P; Puri S; Chakraborti P
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):209. PubMed ID: 17359909
[No Abstract] [Full Text] [Related]
47. Radiation-induced pancreatitis: search for the neoplasm!
Landreau P; Facy O; Ravoire A; Holl S; Guiu B; Jouve JL; Rat P
Clin Res Hepatol Gastroenterol; 2012 Jun; 36(3):e48-9. PubMed ID: 22285641
[TBL] [Abstract][Full Text] [Related]
48. Radiotherapy for early stages testicular seminoma: patterns of care study in Germany.
Classen J; Souchon R; Hehr T; Bamberg M
Radiother Oncol; 2002 May; 63(2):179-86. PubMed ID: 12063007
[TBL] [Abstract][Full Text] [Related]
49. Hematopoietic bone marrow recovery after radiation therapy: MRI evaluation.
Casamassima F; Ruggiero C; Caramella D; Tinacci E; Villari N; Ruggiero M
Blood; 1989 May; 73(6):1677-81. PubMed ID: 2713500
[TBL] [Abstract][Full Text] [Related]
50. Is it time for bone marrow sparing radiation therapy to be standard of care in cervical cancer?
Ayala-Peacock DN; Chino JP
Cancer; 2023 Jul; 129(13):1962-1965. PubMed ID: 37043344
[No Abstract] [Full Text] [Related]
51. Histological findings in chronic pancreatitis after abdominal radiotherapy.
Schoonbroodt D; Zipf A; Herrmann G; Jung M
Pancreas; 1996 Apr; 12(3):313-5. PubMed ID: 8830341
[No Abstract] [Full Text] [Related]
52. Radiation therapy definitions and reporting guidelines for thymic malignancies.
Gomez D; Komaki R; Yu J; Ikushima H; Bezjak A
J Thorac Oncol; 2011 Jul; 6(7 Suppl 3):S1743-8. PubMed ID: 21847057
[No Abstract] [Full Text] [Related]
53. Reversible CT findings of the liver after radiotherapy.
Gouliamos AD; Kotoulas G; Giannopoulou C; Kalovidouris A; Papavasiliou C
Radiother Oncol; 1991 May; 21(1):67-8. PubMed ID: 1852922
[TBL] [Abstract][Full Text] [Related]
54. Intensity modulated radiation therapy for women with gynecologic cancers: this horse is also already out of the barn.
Kamrava M
Gynecol Oncol; 2016 Oct; 143(1):1-2. PubMed ID: 27650683
[No Abstract] [Full Text] [Related]
55. Low-dose radiotherapy for stage I seminoma: early results.
Niewald M; Schnabel K
Radiother Oncol; 1997 Apr; 43(1):110. PubMed ID: 9165147
[No Abstract] [Full Text] [Related]
56. Proton therapy for seminoma: Case report describing the technique, efficacy, and advantages of proton-based therapy for seminoma.
Haque W; Wages C; Zhu XR; Choi S; Pugh TJ; Frank SJ; Lee A; Mahmood U
Pract Radiat Oncol; 2015; 5(2):135-40. PubMed ID: 25413401
[No Abstract] [Full Text] [Related]
57. The impact of axial tomography on diagnosis and planning in radiotherapy.
Crooks SH
Radiography; 1982 May; 48(569):89-91. PubMed ID: 7111688
[No Abstract] [Full Text] [Related]
58. Pulmonary rehabilitation: a unfairly forgotten therapeutic tool even in the worst scenarios.
Paixão J; Costa JC; Rodrigues C; Costa F; Aleluia L
Rev Assoc Med Bras (1992); 2021 Jun; 67(6):781-784. PubMed ID: 34709316
[No Abstract] [Full Text] [Related]
59. Advances in radiation therapy for testicular seminoma.
Rosen DB; Tan AJN; Pursley J; Kamran SC
World J Urol; 2023 Dec; 41(12):3895-3903. PubMed ID: 37979002
[TBL] [Abstract][Full Text] [Related]
60. Cancer Control, Toxicity, and Secondary Malignancy Risks of Proton Radiation Therapy for Stage I-IIB Testicular Seminoma.
Maxwell R; Chang Y; Paul C; Vaughn DJ; Christodouleas JP
Adv Radiat Oncol; 2023; 8(5):101259. PubMed ID: 37408671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
